A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research
May 22, 2024 10:23 ET
|
Trial Equity
Trial Equity and Miller Tanner Associates are partnering to expand clinical trial participation to address the gap in diversity.
YPrime Transforms Endocrinology and Autoimmune Trials through New Glucometer and eCOA Integrated Functionality
May 21, 2024 08:00 ET
|
Y-Prime, LLC
YPrime's new glucometer/eCOA functionality offers a patient-centric, intuitive, and connected experience to clinical trial participants.
HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REVEALPLAQUE Study
May 15, 2024 12:00 ET
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the data from its...
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
May 13, 2024 08:00 ET
|
Barinthus Biotherapeutics
Barinthus Bio Reports First Quarter 2024 Financial Results and Update on Corporate Developments
DICK's Sporting Goods Long-Term Shareholder Announcement: Johnson Fistel, LLP Encourages Investors to Reach Out For More Information
May 08, 2024 12:22 ET
|
Johnson Fistel, LLP
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of DICK's Sporting Goods (NYSE: DKS) against certain of its officers and directors to hold...
Breaking News: Johnson Fistel, LLP Launches Investigation into Astec
May 01, 2024 11:22 ET
|
Johnson Fistel, LLP
SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Astec Industries, Inc. ("Astec" or "the...
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET
|
Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
OKYO Pharma Announces Upcoming Presentation of OK-101 Phase 2 Data for Dry Eye Disease at the Dry Horizons Symposium, a Partner Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
April 30, 2024 07:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
Phorcys Capital Partners, LLC Acquires Prosper at Wickliffe, Expanding Senior Living Portfolio
April 23, 2024 10:00 ET
|
Phorcys Capital Partners
Phorcys Capital Partners just acquired a 160-unit assisted living facility in Wickliffe, Ohio, now rebranded as Prosper at Wickliffe.
Together Selects nCino to Revolutionise its Lending Business
April 23, 2024 02:30 ET
|
nCino, Inc.
LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced that Together, one of the UK’s leading...